[{"AccountsPayableCurrent_0_Q3_USD":2442000.0,"ProvisionForDoubtfulAccounts_1_Q3_USD":0.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":2225000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":4770000.0,"ProfitLoss_3_Q3_USD":-13933000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":804000.0,"ProceedsFromIssuanceInitialPublicOffering_3_Q3_USD":107610000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":3760000.0,"PreferredStockDividendsAndOtherAdjustments_3_Q3_USD":196000.0,"PreferredStockDividendRatePercentage_3_Q3_pure":0.08,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":1805000.0,"PaymentsOfStockIssuanceCosts_3_Q3_USD":10600000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-3020000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-958000.0,"OtherAccruedLiabilitiesCurrentAndNoncurrent_0_Q3_USD":856000.0,"ProvisionForDoubtfulAccounts_3_Q3_USD":-56000.0,"OperatingLeasesRentExpenseNet_3_Q3_USD":500000.0,"OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_0_Q3_USD":172000.0,"OperatingLeasesFutureMinimumPaymentsDueInTwoYears_0_Q3_USD":694000.0,"OperatingLeasesFutureMinimumPaymentsDueInThreeYears_0_Q3_USD":715000.0,"OperatingLeasesFutureMinimumPaymentsDueInFourYears_0_Q3_USD":722000.0,"OperatingLeasesFutureMinimumPaymentsDue_0_Q3_USD":3578000.0,"OperatingIncomeLoss_3_Q3_USD":-10913000.0,"OperatingIncomeLoss_1_Q3_USD":-5460000.0,"OperatingExpenses_3_Q3_USD":60374000.0,"OperatingExpenses_1_Q3_USD":22831000.0,"NumberOfReportableSegments_3_Q3_Segment":1.0,"NumberOfOperatingSegments_3_Q3_Segment":1.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":-14129000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":-6418000.0,"NetIncomeLoss_3_Q3_USD":-13933000.0,"OperatingLeasesRentExpenseNet_1_Q3_USD":300000.0,"NetIncomeLoss_1_Q3_USD":-6418000.0,"RepaymentsOfLongTermDebt_3_Q3_USD":1788000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":6827000.0,"ValuationAllowanceDeferredTaxAssetChangeInAmount_3_Q3_USD":-2000000.0,"ValuationAllowanceDeferredTaxAssetChangeInAmount_1_Q3_USD":-2000000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_3_Q3_USD":804000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":41000.0,"StockIssuedDuringPeriodValueNewIssues_3_Q3_USD":107610000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":979616.0,"StockholdersEquity_0_Q3_USD":97373000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":17.01,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3_Q3_USD":4.71,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":0.85,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q3_USD":4.66,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q3_shares":8257977.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":4.98,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":8841191.0,"ResearchAndDevelopmentExpense_1_Q3_USD":2537000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":1787761.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":1.36,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":4900066.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3_Q3_pure":0.0067,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q3_pure":0.0088,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3_Q3_pure":0.4245,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q3_pure":0.3629,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3_Q3_pure":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q3_pure":0.0,"ShareBasedCompensation_3_Q3_USD":2116000.0,"SellingAndMarketingExpense_3_Q3_USD":42142000.0,"SellingAndMarketingExpense_1_Q3_USD":15984000.0,"Revenues_3_Q3_USD":60980000.0,"Revenues_1_Q3_USD":21619000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-35286000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q3_shares":415125.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-13441000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-1805000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":106626000.0,"DerivativeLiabilities_0_Q3_USD":200000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":409000.0,"DepreciationDepletionAndAmortization_1_Q3_USD":200000.0,"DeferredTaxAssetsValuationAllowance_0_Q3_USD":3500000.0,"DeferredOfferingCosts_0_Q3_USD":0.0,"DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_0_Q3_USD":679000.0,"DebtInstrumentCarryingAmount_0_Q3_USD":30000000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":11519000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":4248000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":247227031.0,"CommitmentsAndContingencies_0_Q3_USD":null,"CashEquivalentsAtCarryingValue_0_Q3_USD":109256000.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_3_Q3_USD":91380000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":109459000.0,"DerivativeLiabilitiesNoncurrent_0_Q3_USD":173000.0,"Cash_0_Q3_USD":203000.0,"Assets_0_Q3_USD":137590000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":8860215.0,"AmortizationOfFinancingCosts_3_Q3_USD":133000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q3_USD":282000.0,"AllowanceForDoubtfulAccountsReceivable_0_Q3_USD":300000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":2116000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":839000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_3_Q3_USD":2116000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1_Q3_USD":839000.0,"AdditionalPaidInCapital_0_Q3_USD":132614000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":2545000.0,"AccruedRoyaltiesCurrentAndNoncurrent_0_Q3_USD":1171000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":2824000.0,"AccountsReceivableNetCurrent_0_Q3_USD":11795000.0,"AssetsCurrent_0_Q3_USD":135365000.0,"DividendsPreferredStock_3_Q3_USD":2500000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.12,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-0.3,"LongTermDebtNoncurrent_0_Q3_USD":29321000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_0_Q3_USD":30000000.0,"LongTermDebt_0_Q3_USD":29321000.0,"LiabilitiesFairValueAdjustment_3_Q3_USD":72000.0,"LiabilitiesFairValueAdjustment_1_Q3_USD":100000.0,"LiabilitiesCurrent_0_Q3_USD":10723000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":137590000.0,"Liabilities_0_Q3_USD":40217000.0,"IssuanceOfStockAndWarrantsForServicesOrClaims_3_Q3_USD":1000.0,"InvestmentIncomeNet_3_Q3_USD":12000.0,"InvestmentIncomeNet_1_Q3_USD":5000.0,"InventoryWriteDown_3_Q3_USD":179000.0,"InventoryNet_0_Q3_USD":10351000.0,"InterestPaid_3_Q3_USD":2917000.0,"InterestExpense_3_Q3_USD":3032000.0,"InterestExpense_1_Q3_USD":963000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":3168000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q3_pure":0.255,"EffectiveIncomeTaxRateContinuingOperations_3_Q3_pure":0.255,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":2436000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q3_USD":8300000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":4310000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":11405000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":52766150.0,"GrossProfit_1_Q3_USD":17371000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":0.0,"IncomeTaxExpenseBenefit_3_Q3_USD":0.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":177000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":-2747000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":737000.0,"IncreaseDecreaseInInventories_3_Q3_USD":2710000.0,"GrossProfit_3_Q3_USD":49461000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":46603487.0,"Ticker":"TMCI","CIK":"1630627","name":"TREACE MEDICAL CONCEPTS, INC.","OfficialName":"Treace Medical Concepts Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1095075841.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20211104"}]